Global Latent Tuberculosis Infection (LTBI) Testing Market: Insights & Forecast COVID-19 (2021-2025)
The major regional markets (Europe and Middle East, Asia Pacific (Excluding Japan and China) and Latin America) have been analyzed, along with country coverage of the U.S., China and Japan.
By: Koncept Analytics
The latent tuberculosis infection testing market can be segmented on the basis of type, named as Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA). TST being a traditional test for tuberculosis diagnosis is the most recommended test. In the global latent tuberculosis testing market, the tuberculin skin test segment accounted for the higher share in 2020.
The fastest growing regional market is the U.S. due to increasing public awareness about diagnosis and treatment of the disease, growing healthcare expenditure on diagnosis and treatment of LTBI, expanding urbanization, accelerating TB funding. China, Japan and Europe and Middle East are emerging markets where growth lies in rising geriatric population, government expenditure on disease related initiatives and growing prevalence of HIV in the region.
Scope of the report:
For more Information:
(Business Development Manager)
FFCS-36, Ansal Plaza
U.P - 201010
Mail ID – firstname.lastname@example.org